Whitehawk Therapeutics (STU:3350) Valuation Rank


STU:3350 Whitehawk Therapeutics Inc STU:3350
39 GF Score
Price €3.46
GF Value €0.24
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Whitehawk Therapeutics Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Whitehawk Therapeutics Valuation Rank Related Terms

STU:3350
39GF Score
Whitehawk Therapeutics Inc STU:3350
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Whitehawk Therapeutics (STU:3350) Overvalued in 2026?

Based on GuruFocus' analysis, Whitehawk Therapeutics stock appears to be overvalued. The current stock price of €3.46 is trading 1341.7% above its estimated GF Value™ of €0.24. GuruFocus considers Whitehawk Therapeutics to be Significantly Overvalued.

Key valuation signals for STU:3350:

  • Valuation Rank:
  • GF Value™: €0.24 vs. price of €3.46 (1341.7% above fair value)
  • GF Score™: 39/100 with 6 warning signs

No single metric tells the full story. See the STU:3350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Whitehawk Therapeutics Business Description

Other Exchanges WHWK:USA
Address 2 Headquarters Plaza East Building, 11th Floor, Morristown, New Jersey, NJ, USA, 07960
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
39GF Score

Get the complete analysis for STU:3350

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.46
Price
€0.24
GF Value